These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis. Vincent PC, Rutzen-Loesevitz L, Tibken B, Heinze B, Hofer EP, Fliedner TM. Stem Cells; 1999 Aug; 17(1):9-17. PubMed ID: 10215403 [Abstract] [Full Text] [Related]
31. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML. Thiele J, Kvasnicka HM, Zirbes TK, Baldus SE, Djuren O, Lienhard H, Lorenzen J, Leder LD, Niederle N, Fischer R. Hematopathol Mol Hematol; 1996 Aug; 10(4):201-12. PubMed ID: 9042663 [Abstract] [Full Text] [Related]
32. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy. Thiele J, Zirbes TK, Lorenzen J, Kvasnicka HM, Dresbach S, Manich B, Leder LD, Niederle N, Diehl V, Fischer R. J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719 [Abstract] [Full Text] [Related]
33. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations. O'Brien S, Kantarjian HM, Talpaz M, Cork A, Trujillo J, Beran M. Hematol Pathol; 1987 Mar; 1(3):167-72. PubMed ID: 3509052 [Abstract] [Full Text] [Related]
34. Chronic myelocytic leukaemia with unusual (27 years) complete remission terminating in acute undifferentiated leukaemia: a clinical and karyotypic study. Najean Y, Miclea M, Tanzer J, Lessard M, Sigaux F. Leukemia; 1991 Jul; 5(7):621-3. PubMed ID: 2072749 [Abstract] [Full Text] [Related]
35. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors. Lin Y, Bruyère H, Horsman DE, Pantzar T, Barnett MJ, Hogge DE, Nevill TJ, Nantel SH, Sutherland HJ, Toze CL, Shepherd JD, Lavoie JC, Song KW, Smith CA, Forrest DL. Cancer Genet Cytogenet; 2006 Oct 01; 170(1):16-23. PubMed ID: 16965950 [Abstract] [Full Text] [Related]
36. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia. Honda H, Miyagawa K, Endo M, Takaku F, Yazaki Y, Hirai H. Int J Hematol; 1993 Jun 01; 57(3):221-7. PubMed ID: 8364186 [Abstract] [Full Text] [Related]
40. Estimation of chronic phase duration in Ph-positive chronic myelocytic leukemia treated with busulfan: statistical analysis on Japanese patients. Hashimoto T, Ohtaki M, Ueoka H, Munaka M, Kuramoto A, Kamada N. Int J Hematol; 1994 Jul 01; 60(1):59-69. PubMed ID: 7919239 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]